Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

 
(Mark One)
[X]     Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 29, 2002

OR

         
[   ]     Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File No.   0-11007

EMULEX CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of incorporation or organization)

3535 Harbor Boulevard
Costa Mesa, California

(Address of principal executive offices)
  51-0300558
(I.R.S Employer Identification No.)

92626
(Zip Code)

(714) 662-5600

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [   ]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [ X ] No [   ]

As of November 5, 2002, the registrant had 81,950,169 shares of common stock outstanding.




TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Notes to Condensed Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Qualitative and Quantitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II: OTHER INFORMATION
Item 1. Legal Proceedings.
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EXHIBIT 3.3
EXHIBIT 99.1


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES

INDEX

           
      PAGE
     
Part I. FINANCIAL INFORMATION
       
Item 1. Financial Statements
       
 
Condensed Consolidated Balance Sheets September 29, 2002 and June 30, 2002
    2  
 
Condensed Consolidated Statements of Operations Three months ended September 29, 2002 and September 30, 2001
    3  
 
Condensed Consolidated Statements of Cash Flows Three months ended September 29, 2002 and September 30, 2001
    4  
 
Notes to Condensed Consolidated Financial Statements
    5  
Item 2. Management’s Discussion and Analysis of
       
 
Financial Condition and Results of Operations
    11  
Item 3. Qualitative and Quantitative Disclosures about Market Risk
    30  
Item 4. Controls and Procedures
    30  
Part II. OTHER INFORMATION
       
Item 1. Legal Proceedings
    30  
Item 6. Exhibits and Reports on Form 8-K
    32  
Signatures
    34  

1


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
(unaudited)

                     
        September 29,   June 30,
        2002   2002
       
 
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 129,406     $ 282,561  
 
Restricted cash
    1,740       2,024  
 
Investments
    192,747       227,905  
 
Accounts and other receivables, net
    40,521       36,259  
 
Inventories, net
    18,376       14,833  
 
Prepaid expenses
    3,768       3,779  
 
Deferred income taxes
    37,536       30,205  
 
 
   
     
 
   
Total current assets
    424,094       597,566  
 
Property and equipment, net
    18,376       18,574  
 
Investments
    224,092       119,302  
 
Goodwill, net
    397,256       397,256  
 
Other intangibles, net
    31,421       32,874  
 
Deferred income taxes
    5,136       29,385  
 
Other assets
    7,908       12,407  
 
 
   
     
 
 
  $ 1,108,283     $ 1,207,364  
 
 
   
     
 
Liabilities and Stockholders’ Equity
               
 
Current liabilities:
               
 
Accounts payable
  $ 16,601     $ 12,663  
 
Accrued liabilities
    18,474       19,677  
 
Income taxes payable
    8,391       7,020  
 
 
   
     
 
   
Total current liabilities
    43,466       39,360  
 
Convertible subordinated notes
    208,518       345,000  
 
 
   
     
 
 
    251,984       384,360  
 
 
   
     
 
 
Commitments and contingencies (note 7)
               
 
Stockholders’ equity:
               
   
Preferred stock, $0.01 par value; 1,000,000 shares authorized (150,000 shares designated as Series A Junior Participating Preferred Stock); none issued and outstanding
           
 
Common stock, $0.10 par value; 240,000,000 shares authorized; 81,876,248 and 81,800,909 issued and outstanding at September 29, 2002, and June 30, 2002, respectively
    8,188       8,180  
 
Additional paid-in capital
    899,263       898,803  
 
Deferred compensation
    (6,310 )     (7,156 )
 
Accumulated deficit
    (44,842 )     (76,823 )
 
 
   
     
 
   
Total stockholders’ equity
    856,299       823,004  
 
 
   
     
 
 
  $ 1,108,283     $ 1,207,364  
 
 
   
     
 
    See accompanying notes to condensed consolidated financial statements.

2


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)

                     
        Three Months Ended
       
September 29,   September 30,
        2002   2001
       
 
Net revenues
  $ 70,425     $ 52,744  
Cost of sales
    27,882       38,964  
 
   
     
 
 
Gross profit
    42,543       13,780  
 
   
     
 
Operating expenses:
               
 
Engineering and development
    13,673       10,909  
 
Selling and marketing
    4,664       5,299  
 
General and administrative
    2,746       2,847  
 
Amortization of goodwill and other intangibles
    1,453       39,064  
 
   
     
 
   
Total operating expenses
    22,536       58,119  
 
   
     
 
   
Operating income (loss)
    20,007       (44,339 )
 
   
     
 
Nonoperating income:
               
 
Gain on repurchase of convertible subordinated notes
    28,729        
 
Interest income
    3,702       2,603  
 
Interest expense
    (1,804 )     (6 )
 
Other income (expense), net
    (30 )     122  
 
   
     
 
   
Total nonoperating income
    30,597       2,719  
 
   
     
 
Income (loss) before income taxes
    50,604       (41,620 )
Income tax provision (benefit)
    18,623       (1,587 )
 
   
     
 
Net income (loss)
  $ 31,981     $ (40,033 )
 
   
     
 
Net income (loss) per share:
               
 
Basic
  $ 0.39     $ (0.49 )
 
   
     
 
 
Diluted
  $ 0.37     $ (0.49 )
 
   
     
 
Number of shares used in per share computations:
               
 
Basic
    81,844       81,754  
 
   
     
 
 
Diluted
    89,166       81,754  
 
   
     
 
    See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

                       
          Three Months Ended
         
          September 29,   September 30,
          2002   2001
         
 
Cash flows from operating activities:
               
Net income (loss)
  $ 31,981     $ (40,033 )
 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
   
Depreciation and amortization of property and equipment
    2,532       1,766  
   
Gain on repurchase of convertible subordinated notes
    (28,729 )      
   
Stock-based compensation
    846       954  
   
Amortization of goodwill and other intangibles
    1,453       39,064  
   
Loss on disposal of property and equipment
    24        
   
Deferred income taxes
    16,918        
   
Tax benefit from exercise of stock options
    287        
   
Provision for doubtful accounts
    56       105  
   
Changes in assets and liabilities:
               
     
Accounts and other receivables
    (4,318 )     204  
     
Inventories
    (3,543 )     13,248  
     
Income taxes receivable
          (1,587 )
     
Prepaid expenses and other assets
    749       (145 )
     
Accounts payable
    3,938       (7,815 )
     
Accrued liabilities
    (1,026 )     3,647  
     
Income taxes payable
    1,371       (10 )
 
   
     
 
 
Net cash provided by operating activities
    22,539       9,398  
 
   
     
 
Cash flows from investing activities:
               
Additions to property and equipment
    (2,358 )     (2,346 )
Decrease in restricted cash related to construction escrow account
    284        
Purchases of investments
    (228,771 )     (119,297 )
Maturities of investments
    159,139       123,057  
 
   
     
 
 
Net cash provided by (used in) investing activities
    (71,706 )     1,414  
 
   
     
 
Cash flows from financing activities:
               
Proceeds from issuance of common stock under stock option plans
    181       274  
Repurchase of common stock
          (10,539 )
Repurchase of convertible subordinated notes
    (104,169 )      
 
   
     
 
 
Net cash used in financing activities
    (103,988 )     (10,265 )
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    (153,155 )     547  
Cash and cash equivalents at beginning of period
    282,561       36,471  
 
   
     
 
Cash and cash equivalents at end of period
  $ 129,406     $ 37,018  
 
   
     
 
Supplemental disclosures:
               
Cash paid during the period for:
               
 
Interest
  $ 3,052     $ 6  
 
Income taxes
    502       10  


    See accompanying notes to condensed consolidated financial statements.

4


Table of Contents

EMULEX CORPORATION AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements

1.   Summary of Significant Accounting Policies and Basis of Presentation
 
    In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments (which are normal recurring accruals) necessary to present fairly the financial position as of September 29, 2002, and June 30, 2002, and the condensed consolidated statements of operations for the three months ended September 29, 2002, and September 30, 2001, and the condensed consolidated statements of cash flows for the three month periods then ended. Certain reclassifications have been made to the condensed consolidated balance sheet as of June 30, 2002, to conform to the presentation as of September 29, 2002. Interim results for the three months ended September 29, 2002, are not necessarily indicative of the results that may be expected for the year ending June 29, 2003. The interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2002.
 
    Effective July 1, 2002, the Company adopted Financial Accounting Standards Board (“FASB”) Statement (“Statement”) 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” under which the recoverability of long-lived assets is assessed by determining whether the carrying value of an asset can be recovered through projected undiscounted future operating cash flows over its remaining life. The amount of impairment, if any, is measured based on fair value, which is determined using projected discounted future operating cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
 
2.   Inventories
 
    Inventories, net, are summarized as follows:

                 
    September 29,   June 30,
    2002   2002
   
 
    (in thousands)
Raw materials
  $ 6,021     $ 4,166  
Finished goods
    12,355       10,667  
 
   
     
 
 
  $ 18,376     $ 14,833  
 
   
     
 

    Starting in late September 2001, some of the Company’s major customers made announcements that general economic conditions, exacerbated by the increase in economic uncertainty in the aftermath of the terrorist events of September 11, 2001, were having a negative impact on their financial results. The announcements made, and forecasts received, indicated deteriorating demand for the Company’s one gigabit per second (“Gbps”) products as these customers were expected to migrate to two Gbps products for future purchases. As a result, the Company recorded an excess and obsolete inventory charge totaling $13.6 million during the first quarter of fiscal 2002. Subsequently, as a result of the sale of products for which a reserve had been recorded, the Company recorded a reduction of $0.2 million of this excess and obsolete inventory charge for the first three months of fiscal 2003 ended September 29, 2002. As of September 29, 2002, the remaining reserve for one Gbps products was $8.2 million. As with all inventory, the Company regularly compares forecasted demand for its one Gbps products against inventory on hand and open purchase commitments. Accordingly, the Company may have to increase excess and obsolete inventory reserves as forecasted demand changes. As of September 29, 2002, the Company had unreserved inventory on hand of approximately $4.1 million related to its one Gbps products.

5


Table of Contents

3.   Goodwill and Other Intangibles
 
    Goodwill and other intangibles, net, are as follows:

                     
        September 29,   June 30,
        2002   2002
       
 
        (in thousands)
Intangible assets not subject to amortization:
               
 
Goodwill, net
  $ 397,256     $ 395,470  
 
Assembled workforce, net
          1,786  
 
   
     
 
   
Intangible assets not subject to amortization
  $ 397,256     $ 397,256  
 
   
     
 
Intangible assets subject to amortization:
               
 
Core technology and patents
  $ 40,600     $ 40,600  
   
Accumulated amortization, Core technology and patents
    (9,183 )     (7,733 )
 
Completed technology
    20       20  
   
Accumulated amortization, Completed technology
    (16 )     (13 )
 
   
     
 
   
Intangible assets subject to amortization
  $ 31,421     $ 32,874  
 
   
     
 

    Effective July 1, 2002, the Company adopted Statement 142. As a result, the Company ceased amortizing goodwill of $397.3 million beginning July 1, 2002. Included in goodwill is $1.8 million of assembled workforce that was reclassified to goodwill effective July 1, 2002. In conjunction with the adoption of Statement 142, the Company completed its transitional goodwill impairment test for its one reporting unit during the three months ended September 29, 2002, with no impairment charges resulting. The goodwill will be tested for impairment at least annually.
 
    The intangible assets subject to amortization are being amortized on a straight-line basis over the following estimated useful lives:

         
Core technology and patents
    7  
Completed technology
    2  

    Aggregated amortization expense for the three months ended September 29, 2002, was $1.5 million and for the next five fiscal years is expected to be (in thousands):

         
For fiscal year ended 2003
  $ 5,807  
For fiscal year ended 2004
  $ 5,800  
For fiscal year ended 2005
  $ 5,800  
For fiscal year ended 2006
  $ 5,800  
For fiscal year ended 2007
  $ 5,800  

6


Table of Contents

    The following table presents the impact on net income (loss) and net income (loss) per share had Statement 142 been in effect for the three months ended September 30, 2001.

                   
      Three Months Ended
     
      September 29,   September 30,
      2002   2001
     
 
      (in thousands, except per share data)
Net income (loss)
  $ 31,981     $ (40,033 )